New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
10:11 EDTCNC, JNS, SAVE, GWPH, IAUHigh option volume stocks: CNC JNS SAVE GWPH IAU
News For CNC;JNS;SAVE;GWPH;IAU From The Last 14 Days
Check below for free stories on CNC;JNS;SAVE;GWPH;IAU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 26, 2014
16:15 EDTJNSOn The Fly: Closing Wrap
Stocks on Wall Street were higher, regaining much of their losses from yesterday, after GDP data showed the U.S. economy grew at its fastest pace in more than 2 years during the second quarter. Also helping improve sentiment was the significant earnings beat from Dow member Nike (NKE). ECONOMIC EVENTS: In the U.S., second quarter real GDP growth was revised up to 4.6% in the government's third estimate. This was raised from the prior 4.2% growth estimate, though the upward revision had been expected by analysts. The final University of Michigan consumer sentiment index for September came in at 84.6, which was unchanged from the preliminary print but up from the final August reading of 82.5. COMPANY NEWS: Shares of Nike climbed $9.75, or 12.23%, to $89.50 after the company reported stronger than expected results and provided better than expected profit guidance. Following last night's report, a number of analysts reacted positively in notes this morning, including Janney Capital, which upgraded the stock to Buy from Neutral. Meanwhile, Deutsche Bank upgraded Under Armour (UA) to Buy, citing continued sector strength evidenced in Nike's results. Under Armour gained $2.27, or 3.36%, to $69.82 following the report from the industry leader and Deutsche's ratings action. MAJOR MOVERS: Among the notable gainers was Janus Capital (JNS), which surged $4.60, or 41.43%, to $15.72 after the company unexpectedly announced that "Bond King" Bill Gross, formerly of PIMCO, will join as a fund manager this Monday. Afterward, Citigroup upgraded Janus to Neutral from Sell, citing Gross' hiring. Also higher was Yahoo (YHOO), which jumped $1.71, or 4.39%, to $40.66 after activist investor Starboard Value announced it has acquired a significant ownership stake in the company and urged it to explore a strategic combination with AOL (AOL). Shares of AOL also rose $1.58, or 3.68%, to $44.55 following Starboard's public disclosure of its recommendation to Yahoo. Among the noteworthy losers was Finish Line (FINL), which was left out of the Nike-fueled rally in the sneaker sector and fell $4.30, or 14.62%, to $25.11 after the company reported second quarter earnings and revenue that missed expectations. Following Finish Line's Q2 report, the stock and peer Foot Locker (FL) were both downgraded to Neutral from Buy at Bank of America Merrill Lynch. Also lower were shares of AcelRx (ACRX), which fell $1.31, or 19.49%, to $5.41 and was downgraded to Neutral at Roth Capital after the company said it has to resubmit for FDA approval of its Zalviso drug. INDEXES: The Dow advanced 167.35, or 0.99%, to 17,113.15, the Nasdaq gained 45.45, or 1.02%, to 4,512.19, and the S&P 500 rose 16.86, or 0.86%, to 1,982.85.
16:01 EDTJNSOptions Update; September 26, 2014
Subscribe for More Information
15:46 EDTJNSOptions expected to be active next week
Subscribe for More Information
12:38 EDTJNSJanus Capital upgraded to Neutral from Sell at Citigroup
Citigroup upgraded Janus Capital to Neutral citing the hiring of Bill Gross.
11:16 EDTJNSOptions with increasing implied volatility
Subscribe for More Information
11:00 EDTJNSJanus Capital trades down from earlier highs, levels to watch
Subscribe for More Information
10:51 EDTJNSJanus Capital fixed income could grow to $65B-$70B, says Credit Suisse
Subscribe for More Information
10:39 EDTJNSJanus Capital volatility spikes on William H. Gross joining
Subscribe for More Information
10:09 EDTJNSHigh option volume stocks
Subscribe for More Information
09:54 EDTJNSPIMCO would have fired Bill Gross tomorrow, CNBC reports
Subscribe for More Information
09:03 EDTJNSOn The Fly: Pre-market Movers
Subscribe for More Information
08:41 EDTJNSProshares UltraShort Barc 20 Year Treasury volatility flat
Proshares UltraShort Barc 20 Year Treasury ETF October weekly call option implied volatility is at 29, October is at 23, November and December is at 22; compared to its 26-week average of 22 according to Track Data, suggesting large near term price movement.
08:37 EDTJNSJanus Capital jumps 17% to $13.00 after employing Bill Gross
Subscribe for More Information
08:36 EDTJNSJanus Capital says Bill Gross joins company as fund manager
Janus Capital Group announced that Bill Gross will be joining Janus Capital Group. He will manage a recently launched Janus Global Unconstrained Bond Fund and related strategies, and will join Myron Scholes, Ph.D., and other members of the Janus team focused on global asset allocation, the company said. Grossí employment will be effective September 29, and he will begin managing the Janus Global Unconstrained Bond Fund and related strategies effective October 6. Gross will be based in a new Janus office to be established in Newport Beach, California and will be "responsible for building-out the firmís efforts in global macro fixed income strategies."
September 25, 2014
10:24 EDTGWPHGW Pharmaceuticals management to meet with Leerink
Subscribe for More Information
September 24, 2014
06:45 EDTCNCGovernment says more health insurers to enter exchanges in 2015, NY Times says
Subscribe for More Information
September 22, 2014
07:51 EDTGWPHGW Pharmaceuticals could trade up 25% on data, says Leerink
Leerink believes shares of GW Pharmaceuticals could trade up 25% should the Epidiolex data in pediatric epilepsy show a seizure reduction materially greater than 44%. The data is expected in the second half of 2014. The firm says shares could trade up 15% higher on a reduction at or close to 40%, or 15% lower if the mean reduction is in the 20%-30% range. Leerink is bullish ahead of the data readout after reviewing the cannabidiol epilepsy literature and previous anti-epileptic drug trials. It has an Outperform rating on shares of GW Pharmaceuticals with a $110 price target.
September 19, 2014
06:49 EDTCNCGovernment says 7.3M in private Obamacare plans, NY Times reports
Subscribe for More Information
September 18, 2014
09:46 EDTJNSJanus Capital initiated with a Strong Sell at Off Wall Street Research at undefined
Subscribe for More Information
07:52 EDTCNCCentene subsidiary Sunshine Health awarded Commendable Accreditation from NCQA
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use